While the effect of T-cells on disease outcome has been well defined, with cytotoxic CD8+ T cell infiltration correlating with favorable outcomes in multiple studies and CD4+ subsets sustaining effective anti-tumor immunity [3,4,5], the role of B-cells is yet to be fully understood. The gene discussed is CD4; the disease is neoplasm.